Sangamo Therapeutics (SGMOQ) Q2 2026 Earnings

14MayConfirmed
Q2 2026
-0.08
-0.05
-0.02
0.01

Details

Expected EPS
0.005
Actual EPS
-0.08
Surprise EPS
-0.09
Surprise Percent
+1,700%

Description

Sangamo Therapeutics (SGMOQ) has reported earnings of -0.08 per share for Q2 2026.

0 Comments

Share your thoughts